Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Recording and Investigating Non-Conformance Reports – V 2.0

Posted on By

SOP for Recording and Investigating Non-Conformance Reports – V 2.0

Procedure for Recording and Investigating Non-Conformance Reports

Department Quality Assurance (QA)/Quality Control (QC)/Production
SOP No. SOP/Ointment/163
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for recording and investigating non-conformance reports (NCRs) in pharmaceutical manufacturing. Proper documentation and investigation of non-conformances ensure compliance with Good Manufacturing Practices (GMP) and regulatory requirements while maintaining product quality.

2. Scope

This SOP applies to personnel in the Quality Assurance (QA), Quality Control (QC), and Production departments responsible for identifying, documenting, investigating, and resolving non-conformances observed in materials, processes, equipment, and final products.

3. Responsibilities

  • Production Supervisor: Identifies non-conformances and initiates NCRs.
  • QC Analyst: Evaluates non-conformances related to product quality and testing.
  • QA Officer: Reviews NCRs and initiates investigations.
  • CAPA Coordinator: Implements corrective and preventive actions.
  • QA Manager: Approves NCR resolutions and ensures compliance.
See also  Ointments: SOP for Deaeration of Ointment Mixture - V 2.0

4. Accountability

The QA and Production Managers are accountable for ensuring that all non-conformance reports are documented, investigated, and resolved in compliance with GMP, FDA, ICH, and WHO regulations.

5. Procedure

5.1 Identification of Non-Conformances

Non-conformances can occur at various stages of manufacturing and include:

  • Material Non-Conformance: Raw materials or packaging materials that do not meet specified standards.
  • Process Non-Conformance: Deviations
from standard operating procedures (SOPs) in manufacturing.
  • Product Non-Conformance: Finished products failing to meet quality standards.
  • Equipment Non-Conformance: Malfunctions or deviations in equipment performance.
  • Documentation Non-Conformance: Errors or omissions in records and logbooks.
  • 5.2 Initiating a Non-Conformance Report (NCR)

    • Any personnel identifying a non-conformance must report it to the **Production Supervisor or QA Officer** immediately.
    • An **NCR Form** must be completed, capturing the following details:
      • Date and time of occurrence.
      • Location and process step affected.
      • Description of the non-conformance.
      • Immediate actions taken.
      • Person reporting the issue.
    • The NCR form must be submitted to QA within **24 hours** of identification.

    5.3 Investigation of Non-Conformance

    • QA must initiate an **investigation within 48 hours** of receiving an NCR.
    • Investigation steps include:
      • Reviewing batch records and process logs.
      • Conducting interviews with personnel involved.
      • Analyzing raw material and finished product test results.
      • Inspecting equipment and calibration records.
    • The **Root Cause Analysis (RCA)** must be documented in the **NCR Investigation Report.**
    • Critical non-conformances must be escalated to senior management.

    5.4 Corrective and Preventive Action (CAPA)

    • Based on the investigation findings, a **CAPA Plan** must be developed.
    • Corrective Actions:
      • Immediate measures to correct the identified non-conformance.
      • Batch rejection or product recall if necessary.
      • Training of personnel if human error is identified.
    • Preventive Actions:
      • Updating SOPs and work instructions.
      • Enhancing equipment calibration and maintenance programs.
      • Implementing additional quality control checks.
    • The CAPA plan must be reviewed and approved by the **QA Manager.**

    5.5 Implementation and Verification of CAPA

    • The CAPA Coordinator must track the implementation of corrective and preventive actions.
    • A **CAPA Effectiveness Check** must be conducted **one month after implementation.**
    • QA must verify that the non-conformance has not recurred.

    5.6 Closure and Documentation of NCRs

    • QA must ensure all NCRs are properly documented and closed within the required time frame.
    • NCR reports and CAPA records must be reviewed **monthly.**
    • All NCRs must be archived for **a minimum of 5 years.**

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • NCR – Non-Conformance Report
    • CAPA – Corrective and Preventive Action
    • RCA – Root Cause Analysis
    • FDA – Food and Drug Administration
    • ICH – International Council for Harmonisation

    7. Documents

    • Non-Conformance Report Template (Annexure-1)
    • CAPA Implementation Log (Annexure-2)

    8. References

    • ICH Q10 – Pharmaceutical Quality System
    • WHO Guidelines on Deviation and CAPA Management
    • US FDA Guidance on CAPA Implementation

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Non-Conformance Report Template

    Date Process Step Non-Conformance Description Reported By QA Review
    02/02/2025 Mixing Process Temperature exceeded by 2°C John Doe Reviewed

    Annexure-2: CAPA Implementation Log

    Date CAPA Action Responsible Person Completion Date Effectiveness Check
    02/02/2025 Temperature alarm system installed Jane Smith 05/02/2025 Verified

    12. Revision History

    See also  Ointments: SOP for Validation of HVAC Systems - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Capsule: SOP for Handling Capsule Variability in High-Speed Machines – V 2.0
    Next Post: Capsule: SOP for Processing Overages in Capsule Formulations – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version